Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 4/2023

16.06.2023 | Clinical Report

Locally Advanced Laryngeal Squamous cell Carcinoma in a Patient with a Synchronous Second Primary Thyroid Carcinoma

verfasst von: Evropi Forozidou, Georgios Fyrmpas, Nikoleta Pasteli, Ioannis Emmanouil, Chrysoula Vardaxi, Paraskevi Karamitsou, Despoina Beka, Irene Asouhidou, Alexandros Poutoglidis

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Laryngeal squamous cell carcinoma (SCC) is one of the most common primary tumors of the head and neck region. Unfortunately, patients with laryngeal SCC tend to develop second primary tumors (SPTs), accounting for increased mortality. The lung is the predominant site of a second presentation, followed by the mucosa of the upper aerodigestive tract. In contrast, the thyroid gland rarely hosts an SPT. Our study describes the management and treatment of a 69-year-old female who presented with a rare combination of synchronous laryngeal and thyroid carcinomas.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Esposito ED, Bevilacqua L, Guadagno MT (2000) Multiple primary malignant neoplasm in patients with laryngeal carcinoma. J Surg Oncol 74(1):83–86CrossRefPubMed Esposito ED, Bevilacqua L, Guadagno MT (2000) Multiple primary malignant neoplasm in patients with laryngeal carcinoma. J Surg Oncol 74(1):83–86CrossRefPubMed
2.
Zurück zum Zitat Escher A, Piotet E, Waridel F, Iggo R, Monnier P (2009) p53 mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients. Eur Arch Otorhinolaryngol 266(4):547–551CrossRefPubMed Escher A, Piotet E, Waridel F, Iggo R, Monnier P (2009) p53 mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients. Eur Arch Otorhinolaryngol 266(4):547–551CrossRefPubMed
3.
Zurück zum Zitat Obid R, Redlich M, Tomeh C (2019) The treatment of Laryngeal Cancer. Oral Maxillofac Surg Clin North Am 31(1):1–11CrossRefPubMed Obid R, Redlich M, Tomeh C (2019) The treatment of Laryngeal Cancer. Oral Maxillofac Surg Clin North Am 31(1):1–11CrossRefPubMed
4.
Zurück zum Zitat Tsetsos N, Poutoglidis A, Vlachtsis K, Stavrakas M, Nikolaou A, Fyrmpas G (2021) Twenty-year experience with salvage total laryngectomy: lessons learned. J Laryngol Otol 135(8):729–736CrossRefPubMed Tsetsos N, Poutoglidis A, Vlachtsis K, Stavrakas M, Nikolaou A, Fyrmpas G (2021) Twenty-year experience with salvage total laryngectomy: lessons learned. J Laryngol Otol 135(8):729–736CrossRefPubMed
5.
Zurück zum Zitat Gan SJ, Dahlstrom KR, Peck BW et al (2013) Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer 119(14):2593–2601CrossRefPubMed Gan SJ, Dahlstrom KR, Peck BW et al (2013) Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer 119(14):2593–2601CrossRefPubMed
6.
Zurück zum Zitat Shimizu N, Okamoto H, Koyama S, Yane K, Hosoi H, Okamura R (2008) Laryngeal carcinoma in a non-smoker female patient with thyroid carcinoma: report of a case. Auris Nasus Larynx 35(4):572–575CrossRefPubMed Shimizu N, Okamoto H, Koyama S, Yane K, Hosoi H, Okamura R (2008) Laryngeal carcinoma in a non-smoker female patient with thyroid carcinoma: report of a case. Auris Nasus Larynx 35(4):572–575CrossRefPubMed
7.
Zurück zum Zitat Morris LG, Sikora AG, Hayes RB, Patel SG, Ganly I (2011) Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control 22(5):671–679CrossRefPubMedPubMedCentral Morris LG, Sikora AG, Hayes RB, Patel SG, Ganly I (2011) Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control 22(5):671–679CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Patrucco MS, Aramendi MV (2016) Prognostic impact of second primary tumors in head and neck cancer. Eur Arch Otorhinolaryngol 273(7):1871–1877CrossRefPubMed Patrucco MS, Aramendi MV (2016) Prognostic impact of second primary tumors in head and neck cancer. Eur Arch Otorhinolaryngol 273(7):1871–1877CrossRefPubMed
9.
Zurück zum Zitat León X, Ferlito A, Myer CM 3rd et al (2002) Second primary tumors in head and neck cancer patients. Acta Otolaryngol 122(7):765–778CrossRefPubMed León X, Ferlito A, Myer CM 3rd et al (2002) Second primary tumors in head and neck cancer patients. Acta Otolaryngol 122(7):765–778CrossRefPubMed
10.
Zurück zum Zitat Chuang SC, Scelo G, Tonita JM et al (2008) Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 123:2390–2396CrossRefPubMed Chuang SC, Scelo G, Tonita JM et al (2008) Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 123:2390–2396CrossRefPubMed
11.
Zurück zum Zitat Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR (1995) Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 75(6):1343–1353CrossRefPubMed Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR (1995) Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 75(6):1343–1353CrossRefPubMed
12.
Zurück zum Zitat Rennemo E, Zätterström U, Boysen M (2008) Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope 118(8):1350–1356CrossRefPubMed Rennemo E, Zätterström U, Boysen M (2008) Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope 118(8):1350–1356CrossRefPubMed
13.
Zurück zum Zitat Lin K, Patel SG, Chu PY et al (2005) Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 27(12):1042–1048CrossRefPubMed Lin K, Patel SG, Chu PY et al (2005) Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 27(12):1042–1048CrossRefPubMed
14.
Zurück zum Zitat Shih C, Wang CP, Lou PJ et al (2009) Thyroid cancer incidentally found in radical surgery for laryngeal/hypopharyngeal cancer. Otolaryngol Head Neck Surg 141(3):343–346CrossRefPubMed Shih C, Wang CP, Lou PJ et al (2009) Thyroid cancer incidentally found in radical surgery for laryngeal/hypopharyngeal cancer. Otolaryngol Head Neck Surg 141(3):343–346CrossRefPubMed
15.
Zurück zum Zitat Guzzo M, Quattrone P, Seregni E, Bianchi R, Mattavelli F (2007) Thyroid carcinoma associated with squamous cell carcinoma of the head and neck: which policy? Head Neck 29(1):33–37CrossRefPubMed Guzzo M, Quattrone P, Seregni E, Bianchi R, Mattavelli F (2007) Thyroid carcinoma associated with squamous cell carcinoma of the head and neck: which policy? Head Neck 29(1):33–37CrossRefPubMed
16.
Zurück zum Zitat Shaha A, Hoover E, Marti J, Krespi Y (1988) Is routine triple endoscopy cost-effective in head and neck cancer? Am J Surg 155(6):750–753CrossRefPubMed Shaha A, Hoover E, Marti J, Krespi Y (1988) Is routine triple endoscopy cost-effective in head and neck cancer? Am J Surg 155(6):750–753CrossRefPubMed
17.
Zurück zum Zitat Tsetsos N, Poutoglidis A, Arsos G et al (2022) 18F-FDG-PET/CT interpretation pitfalls in patients with head and neck cancer. Am J Otolaryngol 43(1):103209CrossRefPubMed Tsetsos N, Poutoglidis A, Arsos G et al (2022) 18F-FDG-PET/CT interpretation pitfalls in patients with head and neck cancer. Am J Otolaryngol 43(1):103209CrossRefPubMed
18.
Zurück zum Zitat Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ (2010) (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck 32(3):319–325PubMed Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ (2010) (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck 32(3):319–325PubMed
Metadaten
Titel
Locally Advanced Laryngeal Squamous cell Carcinoma in a Patient with a Synchronous Second Primary Thyroid Carcinoma
verfasst von
Evropi Forozidou
Georgios Fyrmpas
Nikoleta Pasteli
Ioannis Emmanouil
Chrysoula Vardaxi
Paraskevi Karamitsou
Despoina Beka
Irene Asouhidou
Alexandros Poutoglidis
Publikationsdatum
16.06.2023
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 4/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-03968-y

Weitere Artikel der Ausgabe 4/2023

Indian Journal of Otolaryngology and Head & Neck Surgery 4/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.